PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
FarlaLITE dressing 5cm x 5cm square
20033000106
FarlaLITE dressing 5cm x 5cm square Wound Management & Other Dressings Dressings No data available
FarlaSORB dressing 10cm x 10cm square
20031700323
FarlaSORB dressing 10cm x 10cm square Wound Management & Other Dressings Dressings No data available
FarlaSORB dressing 10cm x 20cm rectangular
20031700325
FarlaSORB dressing 10cm x 20cm rectangular Wound Management & Other Dressings Dressings No data available
FarlaSORB dressing 15cm x 20cm rectangular
20031700326
FarlaSORB dressing 15cm x 20cm rectangular Wound Management & Other Dressings Dressings No data available
FarlaSORB dressing 20cm x 20cm square
20031700324
FarlaSORB dressing 20cm x 20cm square Wound Management & Other Dressings Dressings No data available
FarlaSORB dressing 20cm x 30cm rectangular
20031700327
FarlaSORB dressing 20cm x 30cm rectangular Wound Management & Other Dressings Dressings No data available
FarlaSORB dressing 40cm x 60cm rectangular
20031700328
FarlaSORB dressing 40cm x 60cm rectangular Wound Management & Other Dressings Dressings No data available
Farley's Premcare powder
090402000BBMIA0
Proprietary compound enteral nutrition Enteral nutrition Nutrition and Blood No data available
Farley's Soya Formula powder
090401000BBFJA1
Proprietary compound foods for special diets Other food for special diet preparations Nutrition and Blood No data available
Farlutal 100 tablets
0803020H0BCAAAC
Farlutal Medroxyprogesterone acetate Malignant Disease and Immunosuppression No data available
Farlutal 250 tablets
0803020H0BCABAE
Farlutal Medroxyprogesterone acetate Malignant Disease and Immunosuppression No data available
Farlutal 500 suspension for injection 2.5ml vials
0803020H0BCADAB
Farlutal Medroxyprogesterone acetate Malignant Disease and Immunosuppression No data available
Farlutal 500 tablets
0803020H0BCACAG
Farlutal Medroxyprogesterone acetate Malignant Disease and Immunosuppression No data available
Farmactive Alginato dressing 10cm x 10cm
20030200230
Farmactive Alginato dressing 10cm x 10cm Wound Management & Other Dressings Dressings No data available
Farmactive Alginato dressing 10cm x 20cm
20030200231
Farmactive Alginato dressing 10cm x 20cm Wound Management & Other Dressings Dressings No data available
Farmactive Alginato dressing 5cm x 5cm
20030200229
Farmactive Alginato dressing 5cm x 5cm Wound Management & Other Dressings Dressings No data available
Farmactive Alginato Rope dressing 30cm
20030800063
Farmactive Alginato Rope dressing 30cm Wound Management & Other Dressings Dressings No data available
Farydak 10mg capsules
0801050BWBBABAB
Farydak Panobinostat Malignant Disease and Immunosuppression No data available
Farydak 15mg capsules
0801050BWBBACAC
Farydak Panobinostat Malignant Disease and Immunosuppression No data available
Farydak 20mg capsules
0801050BWBBAAAA
Farydak Panobinostat Malignant Disease and Immunosuppression No data available
Fasenra 30mg/1ml solution for injection pre-filled pens
0304020AABBABAB
Fasenra Benralizumab Respiratory System No data available
Fasenra 30mg/1ml solution for injection pre-filled syringes
0304020AABBAAAA
Fasenra Benralizumab Respiratory System No data available
Fasigyn 500mg tablets
0501110G0BBAAAB
Fasigyn Tinidazole Infections No data available
Fasturtec 1.5mg inf vials
1001040U0BBAAAA
Fasturtec Rasburicase Musculoskeletal and Joint Diseases No data available
Fasturtec 7.5mg inf vials
1001040U0BBABAB
Fasturtec Rasburicase Musculoskeletal and Joint Diseases No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.